Filing Details

Accession Number:
0001209191-22-059172
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-01 16:01:54
Reporting Period:
2022-11-29
Accepted Time:
2022-12-01 16:01:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1069308 Acer Therapeutics Inc. ACER Pharmaceutical Preparations (2834) 320426967
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221599 Steve Aselage C/O Acer Therapeutics Inc.
300 Washington Street., Ste 356
Newton MA 02458
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-29 409,836 $1.22 483,741 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct